Genetics of amyotrophic lateral sclerosis

Genetics of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord. The disease leads to the degeneration and death of motor neurons, which are essential for controlling voluntary muscle movement. The genetics of ALS is a complex and rapidly evolving field, with both hereditary (familial ALS) and sporadic cases observed.

Etiology

Approximately 10% of ALS cases are familial (fALS), where the disease runs in families, suggesting a genetic predisposition. The remaining 90% of cases are considered sporadic (sALS) and do not have a clear familial link. However, recent studies suggest that genetics may also play a role in sporadic cases.

Genetic Mutations Associated with ALS

Several genetic mutations have been identified that contribute to the development of ALS. The most common genetic mutations found in familial ALS cases include:

• SOD1 (Superoxide Dismutase 1): The first gene associated with ALS, mutations in SOD1, are found in approximately 20% of familial ALS cases. SOD1 mutations are thought to lead to the production of a toxic protein that damages motor neurons.

• C9orf72: The most common genetic mutation found in both familial and sporadic ALS cases. This mutation involves a hexanucleotide repeat expansion in the C9orf72 gene. It is believed to contribute to ALS through various mechanisms, including RNA toxicity and the production of dipeptide repeat proteins.

• TARDBP (TAR DNA-binding protein): Mutations in the TARDBP gene, which encodes the TDP-43 protein, are found in approximately 4-5% of familial ALS cases. TDP-43 is a critical protein involved in RNA processing, and its aggregation in neurons is a hallmark of ALS.

• FUS (Fused in Sarcoma): Mutations in the FUS gene are associated with approximately 4% of familial ALS cases. Like TDP-43, FUS is involved in RNA processing, and mutations can lead to its mislocalization and aggregation in neurons.

Other less common genetic mutations associated with ALS include those in the ANG (angiogenin), OPTN (optineurin), and VCP (valosin-containing protein) genes, among others.

Genetic Testing and Counseling

Genetic testing for ALS is available and can be particularly informative for individuals with a family history of the disease. Genetic counseling is recommended for individuals considering genetic testing to understand the implications of test results for themselves and their family members.

Research and Future Directions

Research into the genetics of ALS is ongoing, with the aim of understanding the complex interplay between genetic factors and environmental exposures that contribute to the disease. Advances in genetic research have led to the development of new therapeutic targets and treatment strategies. Gene therapy and the targeting of specific genetic mutations hold promise for the future management of ALS.

Conclusion

The genetics of Amyotrophic Lateral Sclerosis is a complex and rapidly advancing field. Understanding the genetic underpinnings of ALS is crucial for developing targeted therapies and improving outcomes for individuals affected by this devastating disease.

NIH genetic and rare disease info

• NIH info on Genetics of amyotrophic lateral sclerosis

Genetics of amyotrophic lateral sclerosis is a rare disease.